HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramin Farzaneh-Far Selected Research

Activities of Daily Living (ADL)

1/2020Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ramin Farzaneh-Far Research Topics

Disease

6Myocardial Infarction
02/2016 - 10/2009
5Inflammation (Inflammations)
01/2019 - 10/2003
5Coronary Artery Disease (Coronary Atherosclerosis)
08/2011 - 08/2009
3Myasthenia Gravis
05/2021 - 01/2020
3Heart Failure
07/2013 - 10/2009
2Ischemia
08/2015 - 10/2010
2Insulin Resistance
09/2012 - 10/2009
2Coronary Disease (Coronary Heart Disease)
09/2011 - 01/2010
2Stroke (Strokes)
08/2011 - 10/2009
2Obesity
08/2011 - 10/2009
1Muscle Weakness
05/2021
1Chronic Disease (Chronic Diseases)
01/2019
1Lupus Nephritis
01/2019
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
03/2016
1Pathologic Constriction (Stenosis)
01/2016
1Acute Coronary Syndrome
08/2015
1Myocardial Ischemia (Ischemic Heart Diseases)
08/2015
1Diabetes Mellitus
07/2013
1Weight Gain
09/2012
1Cardiovascular Diseases (Cardiovascular Disease)
09/2012
1Prediabetic State (Prediabetes)
09/2012
1Dyslipidemias (Dyslipidemia)
09/2012
1Atherosclerosis
09/2012
1Cardiomyopathies (Cardiomyopathy)
08/2012
1Transient Ischemic Attack
08/2011
1Cardiomegaly (Heart Hypertrophy)
10/2010
1Ventricular Dysfunction
10/2010
1Heart Diseases (Heart Disease)
10/2009
1Hypertension (High Blood Pressure)
01/2008
1Cholestasis
10/2003
1Hepatorenal Syndrome
10/2003
1Portal Hypertension
10/2003

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
09/2012 - 08/2009
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
04/2011 - 08/2009
2AutoantibodiesIBA
05/2021 - 01/2020
2zilucoplanIBA
05/2021 - 01/2020
2glucose-mannose-glucoseIBA
05/2021 - 01/2020
2Cholinergic ReceptorsIBA
05/2021 - 01/2020
2RanolazineFDA Link
01/2016 - 08/2015
2AdipokinesIBA
09/2012 - 10/2009
1Complement C5 (Complement 5)IBA
05/2021
1Pharmaceutical PreparationsIBA
01/2020
1Prednisone (Sone)FDA LinkGeneric
01/2020
1Complement Inactivating AgentsIBA
01/2020
1margatoxinIBA
01/2020
1Complement System Proteins (Complement)IBA
01/2019
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2019
1SodiumIBA
03/2016
1Neurofibromin 2 (Merlin)IBA
08/2015
1antineoplaston A10 (A 10)IBA
07/2013
1CholesterolIBA
07/2013
1Glucose (Dextrose)FDA LinkGeneric
09/2012
1Insulin (Novolin)FDA Link
09/2012
1FructosamineIBA
09/2012
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
08/2012
1Biological ProductsIBA
09/2011
1LeptinIBA
08/2011
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
11/2010
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2010
1renalaseIBA
10/2010
1CreatinineIBA
01/2010
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2009
14-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA
01/2008
1LeukotrienesIBA
10/2003

Therapy/Procedure

3Percutaneous Coronary Intervention
02/2016 - 08/2015
1Therapeutics
01/2020
1Thymectomy
01/2020
1Activities of Daily Living (ADL)
01/2020
1Liver Transplantation
01/2008